Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumors

被引：0
|
作者：
Aalbersberg, Else [2 ]
de Wit-van der Veen, Linda [2 ]
Versleijen, Michelle [2 ]
Valk, Gerlof [3 ]
Tesselaar, Margot [1 ]
Stokkel, Marcel [2 ]
机构：
[1] Netherlands Canc Inst, Med Oncol, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Nucl Med, Amsterdam, Netherlands
[3] Univ Med Ctr Utrecht, Endocrine Oncol, Utrecht, Netherlands
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
47
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intrapatient 68Ga-DOTATOC/68Ga-DOTATATE uptake comparison in primary neuroendocrine tumors, metastases and normal liver
    Todorovic-Tirnanic, Mila
    Gajic, Milan
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [22] Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors
    Haug, Alexander R.
    Rominger, Axel
    Mustafa, Mona
    Auernhammer, Christoph
    Goeke, Burkhard
    Schmidt, Gerwin P.
    Waengler, Bjoern
    Cumming, Paul
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (11) : 1679 - 1683
  • [23] Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Wild, Damian
    Bomanji, Jamshed B.
    Benkert, Pascal
    Maecke, Helmut
    Ell, Peter J.
    Reubi, Jean Claude
    Caplin, Martyn E.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (03) : 364 - 372
  • [24] 68Ga-DOTATATE Uptake in Ischemic Stroke
    Vallee, Emilie
    Paquet, Nancy
    Buteau, James Patrick
    Turcotte, Eric
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (01) : 46 - 47
  • [25] A reassessment of the clinical utility of 68Ga-DOTATATE PET/CT in patients with gastroenteropancreatic neuroendocrine tumors
    Prela, Orjola
    Caveney, Brennen
    Strawderman, Myla S.
    Carpizo, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in Primary Neuroendocrine Tumors, Metastases, and Normal Liver Tissue - is there a Significant Difference?
    Todorovic-Tirnanic, M.
    Gajic, M.
    Baum, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S383 - S383
  • [27] PET/CT using 68Ga-DOTATATE for imaging neuroendocrine tumors (NET)
    Amaral, Horacio
    Cecilia Gil, Maria
    Redondo, Francisca
    Lavados, Hugo
    Pruzzo, Rossana
    Coudeu, Irene
    Astudillo, Sergio
    Galaz, Rodrigo
    Baum, Richard
    Roesch, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [28] Clinical impact of 68Ga-DOTATATE in patients with neuroendrocrine tumors
    Tuncel, M.
    Kilickap, S.
    Akdemir, E.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [29] Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in primary neuroendocrine tumors, metastases, and normal liver tissue: is there a significant difference?
    Todorovic-Tirnanic, M.
    Gajic, M. M.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [30] Role of 68Ga-DOTATATE in patients with known or suspected Neuroendocrine Tumours
    Panagiotidis, E.
    Al-Harbi, M.
    Sajjan, R.
    Saad, Z.
    Caplin, M.
    Bomanji, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S252 - S252
12345